Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.4 USD | +2.23% | +1.42% | -17.43% |
01:37pm | ABL Bio, BMS Collaborate on Gastric Cancer Treatment Trial | MT |
Jun. 07 | Geron shares surge after U.S. FDA approves blood disorder drug | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.43% | 84.08B | |
+47.61% | 765B | |
-6.26% | 354B | |
+20.39% | 331B | |
+9.60% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.03% | 164B | |
-2.34% | 162B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Wolfe Research Adjusts Price Target on Bristol-Myers Squibb to $55 From $57, Maintains Outperform Rating